Advances in sequencing technologies have transformed human genetics and accelerated disease gene discovery. Yet a causal mutation remains to be identified for many families with an inherited disease. Incomplete penetrance, genetic heterogeneity, and limited family history can complicate the binary classification of fam...
L. Henden, Sandrine Chan Moi Fat, Andrew N. Smith et al.· Brain : a journal of neurolo...· 0 citations
A modular mass spectrometry-based assay for the analysis of orthologous proteins across species in the context of translational science using ataxin-2 (ATXN2) as an example provides a translational blueprint that can be adapted to other orthologues, reducing cost and timeline in drug development.
Blandine Rougemont, Julie Borgel, Zoe Walker et al.· Journal of Proteome Research· 0 citations
A new model is developed that is validated across diverse ALS populations, can handle discrepancies between genotyping technologies, and is applicable to individual external samples, and has the potential to extend genetic risk assessment to all individuals, regardless of their family history or the presence of known A...
Jia-Jing Hu, Oliver Pain, A. Al Khleifat et al.· Genome Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.